Explain this page
Arphra AIPlain-English read on Dermata Therapeutics, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $6.00 (+387.80%)
Candlestick · 1Y
Open in chart workstation →DRMA
1.20-40.59%H 2.32L 1.10MA50 1.26MA200 —Avg vol 1.3M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.52% | 0.00% | +2.50% | +3.36% | -43.58% | -46.98% | -82.28% | -99.56% | -99.99% | -99.99% | -99.99% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$1.23
14 sh
Bid
$1.21
55 sh
Ask
$1.25
208 sh
Spread
$0.040
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Technology+2.53%
- Communication Services+2.28%
- Utilities+0.64%
- Consumer Cyclical+0.47%
- Consumer Defensive-0.32%
- Industrials-0.48%
- Basic Materials-0.64%
- Energy-0.75%
- Real Estate-0.76%
- Financial Services-1.08%
- Healthcare-1.31%
Top industries (issuer's industry highlighted)
- Biotechnology-4.85%
- Business Equipment & Supplies+6.57%
- Electronic Gaming & Multimedia+6.45%
- Other Precious Metals-4.95%
- Semiconductors+4.52%
- Medical - Equipment & Services+4.26%
- Grocery Stores-4.13%
- Oil & Gas Drilling-3.68%
- Internet Content & Information+3.47%
- Financial - Mortgages+3.40%
- Gold-3.28%
- Oil & Gas Equipment & Services-3.15%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for DRMA.
Peers
No peer list available for DRMA.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|